PubMed Sikiric, P., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L.B., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic, D., Madzarac, G., Rukavina, I., Sucic, M., Baric, M., Staroveski, M., Zoric, Z., Turkalj, I., & Aralica, G
What I'd ask is that you not read thin as non-existent . The company is actively preparing to launch peptide treatments in anticipation of the FDA greenlighting some peptides
Signorile PG, Viceconte R, Baldi A
That last group is the most vulnerable, and it includes a large percentage of people entering the peptide research space for the first time through vendors like Amino Asylum